Hasil Pencarian - Naoyuki Tachibana

  • Menampilkan 1 - 3 hasil dari 3
Perbaiki Hasil
  1. 1
    A novel orally active gonadotropin‐releasing hormone antagonist, relugolix, is a potential substitute for injectable GnRH antagonists in controlled ovarian stimulation in assisted reproductive technology

    A novel orally active gonadotropin‐releasing hormone antagonist, relugolix, is a potential substitute for injectable GnRH antagonists in controlled ovarian stimulation in assisted... oleh Michiko Hamada, Michiharu Horikawa, Chie Ensaka, Megumi Enomoto, Rena Ishii, Rena Toriumi, Naoyuki Tachibana, Yuji Taketani

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    The addition of dydrogesterone improves the outcomes of pregnant women with low progesterone levels when receiving vaginal progesterone alone as luteal support in HRT‐FET cycles

    The addition of dydrogesterone improves the outcomes of pregnant women with low progesterone levels when receiving vaginal progesterone alone as luteal support in HRT‐FET cycles oleh Rena Toriumi, Michiharu Horikawa, Chie Sato, Nagisa Shimamura, Rena Ishii, Michiru Terashima, Michiko Hamada, Naoyuki Tachibana, Yuji Taketani

    Diterbitkan 2023-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Different anti‐Műllerian hormone (AMH) levels respond to distinct ovarian stimulation methods in assisted reproductive technology (ART): Clues to better ART outcomes

    Different anti‐Műllerian hormone (AMH) levels respond to distinct ovarian stimulation methods in assisted reproductive technology (ART): Clues to better ART outcomes oleh Rena Ishii, Naoyuki Tachibana, Riho Okawa, Megumi Enomoto, Mai Asami, Rena Toriumi, Michiko Hamada, Michiharu Horikawa, Yoko Akiba, Yuji Taketani

    Diterbitkan 2019-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: